The two-day event will take place at Emirates Stadium and is expected to welcome more than 700 attendees and 80 speakers across two stages. This year’s programme expands its focus on both the wider forces shaping women’s health and the practical challenges of building and scaling companies in the sector.
Sessions will cover investment, regulation, commercialisation, healthcare systems, emerging technologies and international growth, alongside pitch competitions and networking between companies, investors and potential partners.
One of the discussions, “Passport to Scale: Taking Your Women’s Health Business Global,” will examine what it takes for women’s health companies to expand into new markets.
The panel brings together Annie Theriault, Managing Director at CBIV; Victorine Lançon, CCO at Daya Ventures; and Dr Mridula Pore, CEO of Peppy. It will be moderated by our editor, Vanessa Julia Carpenter.
The discussion comes as more women’s health companies look beyond their domestic markets, requiring founders to navigate different healthcare systems, reimbursement structures, regulatory environments, investment landscapes and routes to market.
For 2026, Women’s Health Week Europe has divided its programme between a Global Stage, focused on areas including policy, regulation and market development, and a Scale Stage, centred on company growth, commercialisation and expansion.
Femtech News EU is a media partner for Women’s Health Week Europe 2026 and will be attending the event in London.
Women’s Health Week Europe 2026
7 - 8 October 2026
Emirates Stadium, London
More information and registration are available through Women’s Health Week Europe.